カテゴリー： Market Monitor Global, 世界, 医療/バイオ

アセタゾラミド薬の世界市場見通し2023年-2029年

◆英語タイトル：Acetazolamide Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5617）

◆商品コード：MMG23JU5617
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月（※2025年版があります。お問い合わせください。）
◆ページ数：71
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Acetazolamide Drug Market 調査レポートは次の情報を含め、グローバルにおけるのアセタゾラミド薬市場規模と予測を収録しています。・世界のアセタゾラミド薬市場：売上、2018年-2023年、2024年-2029年
・世界のアセタゾラミド薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のアセタゾラミド薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「錠剤」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

アセタゾラミド薬のグローバル主要企業は、Teva、 TARO、 Zydus Pharmaceuticals、 Lannett Company、 Sun Pharmaceutical、 Heritage Pharmaceuticals、 Nostrum Laboratories、 Accord Healthcare、 Strides Pharma、 West-Ward Pharmaceuticals、 X-Gen Pharmaceuticals、 Mylan、 Emcureなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、アセタゾラミド薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のアセタゾラミド薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のアセタゾラミド薬市場：タイプ別市場シェア、2022年
・錠剤、カプセル、注射剤

世界のアセタゾラミド薬市場：用途別、2018年-2023年、2024年-2029年
世界のアセタゾラミド薬市場：用途別市場シェア、2022年
・病院、薬局

世界のアセタゾラミド薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のアセタゾラミド薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるアセタゾラミド薬のグローバル売上、2018年-2023年
・主要企業におけるアセタゾラミド薬のグローバル売上シェア、2022年
・主要企業におけるアセタゾラミド薬のグローバル販売量、2018年-2023年
・主要企業におけるアセタゾラミド薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Teva、 TARO、 Zydus Pharmaceuticals、 Lannett Company、 Sun Pharmaceutical、 Heritage Pharmaceuticals、 Nostrum Laboratories、 Accord Healthcare、 Strides Pharma、 West-Ward Pharmaceuticals、 X-Gen Pharmaceuticals、 Mylan、 Emcure

*************************************************************

・調査・分析レポートの概要
アセタゾラミド薬市場の定義
市場セグメント
世界のアセタゾラミド薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のアセタゾラミド薬市場規模
世界のアセタゾラミド薬市場規模：2022年 VS 2029年
世界のアセタゾラミド薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのアセタゾラミド薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のアセタゾラミド薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：錠剤、カプセル、注射剤
アセタゾラミド薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、薬局
アセタゾラミド薬の用途別グローバル売上・予測

・地域別市場分析
地域別アセタゾラミド薬市場規模 2022年と2029年
地域別アセタゾラミド薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Teva、 TARO、 Zydus Pharmaceuticals、 Lannett Company、 Sun Pharmaceutical、 Heritage Pharmaceuticals、 Nostrum Laboratories、 Accord Healthcare、 Strides Pharma、 West-Ward Pharmaceuticals、 X-Gen Pharmaceuticals、 Mylan、 Emcure
...

Acetazolamide is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision. Acetazolamide decreases the pressure in the eye.
This report aims to provide a comprehensive presentation of the global market for Acetazolamide Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acetazolamide Drug. This report contains market size and forecasts of Acetazolamide Drug in global, including the following market information:
Global Acetazolamide Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Acetazolamide Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Acetazolamide Drug companies in 2022 (%)
The global Acetazolamide Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Tablets Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Acetazolamide Drug include Teva, TARO, Zydus Pharmaceuticals, Lannett Company, Sun Pharmaceutical, Heritage Pharmaceuticals, Nostrum Laboratories, Accord Healthcare and Strides Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Acetazolamide Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acetazolamide Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Acetazolamide Drug Market Segment Percentages, by Type, 2022 (%)
Tablets
Capsule
Injection
Global Acetazolamide Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Acetazolamide Drug Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Global Acetazolamide Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Acetazolamide Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acetazolamide Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Acetazolamide Drug revenues share in global market, 2022 (%)
Key companies Acetazolamide Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Acetazolamide Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva
TARO
Zydus Pharmaceuticals
Lannett Company
Sun Pharmaceutical
Heritage Pharmaceuticals
Nostrum Laboratories
Accord Healthcare
Strides Pharma
West-Ward Pharmaceuticals
X-Gen Pharmaceuticals
Mylan
Emcure
Outline of Major Chapters:
Chapter 1: Introduces the definition of Acetazolamide Drug, market overview.
Chapter 2: Global Acetazolamide Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Acetazolamide Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Acetazolamide Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Acetazolamide Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Acetazolamide Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acetazolamide Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acetazolamide Drug Overall Market Size
2.1 Global Acetazolamide Drug Market Size: 2022 VS 2029
2.2 Global Acetazolamide Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Acetazolamide Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Acetazolamide Drug Players in Global Market
3.2 Top Global Acetazolamide Drug Companies Ranked by Revenue
3.3 Global Acetazolamide Drug Revenue by Companies
3.4 Global Acetazolamide Drug Sales by Companies
3.5 Global Acetazolamide Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Acetazolamide Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Acetazolamide Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Acetazolamide Drug Players in Global Market
3.8.1 List of Global Tier 1 Acetazolamide Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Acetazolamide Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Acetazolamide Drug Market Size Markets, 2022 & 2029
4.1.2 Tablets
4.1.3 Capsule
4.1.4 Injection
4.2 By Type – Global Acetazolamide Drug Revenue & Forecasts
4.2.1 By Type – Global Acetazolamide Drug Revenue, 2018-2023
4.2.2 By Type – Global Acetazolamide Drug Revenue, 2024-2029
4.2.3 By Type – Global Acetazolamide Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Acetazolamide Drug Sales & Forecasts
4.3.1 By Type – Global Acetazolamide Drug Sales, 2018-2023
4.3.2 By Type – Global Acetazolamide Drug Sales, 2024-2029
4.3.3 By Type – Global Acetazolamide Drug Sales Market Share, 2018-2029
4.4 By Type – Global Acetazolamide Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Acetazolamide Drug Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application – Global Acetazolamide Drug Revenue & Forecasts
5.2.1 By Application – Global Acetazolamide Drug Revenue, 2018-2023
5.2.2 By Application – Global Acetazolamide Drug Revenue, 2024-2029
5.2.3 By Application – Global Acetazolamide Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Acetazolamide Drug Sales & Forecasts
5.3.1 By Application – Global Acetazolamide Drug Sales, 2018-2023
5.3.2 By Application – Global Acetazolamide Drug Sales, 2024-2029
5.3.3 By Application – Global Acetazolamide Drug Sales Market Share, 2018-2029
5.4 By Application – Global Acetazolamide Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Acetazolamide Drug Market Size, 2022 & 2029
6.2 By Region – Global Acetazolamide Drug Revenue & Forecasts
6.2.1 By Region – Global Acetazolamide Drug Revenue, 2018-2023
6.2.2 By Region – Global Acetazolamide Drug Revenue, 2024-2029
6.2.3 By Region – Global Acetazolamide Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Acetazolamide Drug Sales & Forecasts
6.3.1 By Region – Global Acetazolamide Drug Sales, 2018-2023
6.3.2 By Region – Global Acetazolamide Drug Sales, 2024-2029
6.3.3 By Region – Global Acetazolamide Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Acetazolamide Drug Revenue, 2018-2029
6.4.2 By Country – North America Acetazolamide Drug Sales, 2018-2029
6.4.3 US Acetazolamide Drug Market Size, 2018-2029
6.4.4 Canada Acetazolamide Drug Market Size, 2018-2029
6.4.5 Mexico Acetazolamide Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Acetazolamide Drug Revenue, 2018-2029
6.5.2 By Country – Europe Acetazolamide Drug Sales, 2018-2029
6.5.3 Germany Acetazolamide Drug Market Size, 2018-2029
6.5.4 France Acetazolamide Drug Market Size, 2018-2029
6.5.5 U.K. Acetazolamide Drug Market Size, 2018-2029
6.5.6 Italy Acetazolamide Drug Market Size, 2018-2029
6.5.7 Russia Acetazolamide Drug Market Size, 2018-2029
6.5.8 Nordic Countries Acetazolamide Drug Market Size, 2018-2029
6.5.9 Benelux Acetazolamide Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Acetazolamide Drug Revenue, 2018-2029
6.6.2 By Region – Asia Acetazolamide Drug Sales, 2018-2029
6.6.3 China Acetazolamide Drug Market Size, 2018-2029
6.6.4 Japan Acetazolamide Drug Market Size, 2018-2029
6.6.5 South Korea Acetazolamide Drug Market Size, 2018-2029
6.6.6 Southeast Asia Acetazolamide Drug Market Size, 2018-2029
6.6.7 India Acetazolamide Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Acetazolamide Drug Revenue, 2018-2029
6.7.2 By Country – South America Acetazolamide Drug Sales, 2018-2029
6.7.3 Brazil Acetazolamide Drug Market Size, 2018-2029
6.7.4 Argentina Acetazolamide Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Acetazolamide Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Acetazolamide Drug Sales, 2018-2029
6.8.3 Turkey Acetazolamide Drug Market Size, 2018-2029
6.8.4 Israel Acetazolamide Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Acetazolamide Drug Market Size, 2018-2029
6.8.6 UAE Acetazolamide Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Teva
7.1.1 Teva Company Summary
7.1.2 Teva Business Overview
7.1.3 Teva Acetazolamide Drug Major Product Offerings
7.1.4 Teva Acetazolamide Drug Sales and Revenue in Global (2018-2023)
7.1.5 Teva Key News & Latest Developments
7.2 TARO
7.2.1 TARO Company Summary
7.2.2 TARO Business Overview
7.2.3 TARO Acetazolamide Drug Major Product Offerings
7.2.4 TARO Acetazolamide Drug Sales and Revenue in Global (2018-2023)
7.2.5 TARO Key News & Latest Developments
7.3 Zydus Pharmaceuticals
7.3.1 Zydus Pharmaceuticals Company Summary
7.3.2 Zydus Pharmaceuticals Business Overview
7.3.3 Zydus Pharmaceuticals Acetazolamide Drug Major Product Offerings
7.3.4 Zydus Pharmaceuticals Acetazolamide Drug Sales and Revenue in Global (2018-2023)
7.3.5 Zydus Pharmaceuticals Key News & Latest Developments
7.4 Lannett Company
7.4.1 Lannett Company Company Summary
7.4.2 Lannett Company Business Overview
7.4.3 Lannett Company Acetazolamide Drug Major Product Offerings
7.4.4 Lannett Company Acetazolamide Drug Sales and Revenue in Global (2018-2023)
7.4.5 Lannett Company Key News & Latest Developments
7.5 Sun Pharmaceutical
7.5.1 Sun Pharmaceutical Company Summary
7.5.2 Sun Pharmaceutical Business Overview
7.5.3 Sun Pharmaceutical Acetazolamide Drug Major Product Offerings
7.5.4 Sun Pharmaceutical Acetazolamide Drug Sales and Revenue in Global (2018-2023)
7.5.5 Sun Pharmaceutical Key News & Latest Developments
7.6 Heritage Pharmaceuticals
7.6.1 Heritage Pharmaceuticals Company Summary
7.6.2 Heritage Pharmaceuticals Business Overview
7.6.3 Heritage Pharmaceuticals Acetazolamide Drug Major Product Offerings
7.6.4 Heritage Pharmaceuticals Acetazolamide Drug Sales and Revenue in Global (2018-2023)
7.6.5 Heritage Pharmaceuticals Key News & Latest Developments
7.7 Nostrum Laboratories
7.7.1 Nostrum Laboratories Company Summary
7.7.2 Nostrum Laboratories Business Overview
7.7.3 Nostrum Laboratories Acetazolamide Drug Major Product Offerings
7.7.4 Nostrum Laboratories Acetazolamide Drug Sales and Revenue in Global (2018-2023)
7.7.5 Nostrum Laboratories Key News & Latest Developments
7.8 Accord Healthcare
7.8.1 Accord Healthcare Company Summary
7.8.2 Accord Healthcare Business Overview
7.8.3 Accord Healthcare Acetazolamide Drug Major Product Offerings
7.8.4 Accord Healthcare Acetazolamide Drug Sales and Revenue in Global (2018-2023)
7.8.5 Accord Healthcare Key News & Latest Developments
7.9 Strides Pharma
7.9.1 Strides Pharma Company Summary
7.9.2 Strides Pharma Business Overview
7.9.3 Strides Pharma Acetazolamide Drug Major Product Offerings
7.9.4 Strides Pharma Acetazolamide Drug Sales and Revenue in Global (2018-2023)
7.9.5 Strides Pharma Key News & Latest Developments
7.10 West-Ward Pharmaceuticals
7.10.1 West-Ward Pharmaceuticals Company Summary
7.10.2 West-Ward Pharmaceuticals Business Overview
7.10.3 West-Ward Pharmaceuticals Acetazolamide Drug Major Product Offerings
7.10.4 West-Ward Pharmaceuticals Acetazolamide Drug Sales and Revenue in Global (2018-2023)
7.10.5 West-Ward Pharmaceuticals Key News & Latest Developments
7.11 X-Gen Pharmaceuticals
7.11.1 X-Gen Pharmaceuticals Company Summary
7.11.2 X-Gen Pharmaceuticals Acetazolamide Drug Business Overview
7.11.3 X-Gen Pharmaceuticals Acetazolamide Drug Major Product Offerings
7.11.4 X-Gen Pharmaceuticals Acetazolamide Drug Sales and Revenue in Global (2018-2023)
7.11.5 X-Gen Pharmaceuticals Key News & Latest Developments
7.12 Mylan
7.12.1 Mylan Company Summary
7.12.2 Mylan Acetazolamide Drug Business Overview
7.12.3 Mylan Acetazolamide Drug Major Product Offerings
7.12.4 Mylan Acetazolamide Drug Sales and Revenue in Global (2018-2023)
7.12.5 Mylan Key News & Latest Developments
7.13 Emcure
7.13.1 Emcure Company Summary
7.13.2 Emcure Acetazolamide Drug Business Overview
7.13.3 Emcure Acetazolamide Drug Major Product Offerings
7.13.4 Emcure Acetazolamide Drug Sales and Revenue in Global (2018-2023)
7.13.5 Emcure Key News & Latest Developments
8 Global Acetazolamide Drug Production Capacity, Analysis
8.1 Global Acetazolamide Drug Production Capacity, 2018-2029
8.2 Acetazolamide Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Acetazolamide Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Acetazolamide Drug Supply Chain Analysis
10.1 Acetazolamide Drug Industry Value Chain
10.2 Acetazolamide Drug Upstream Market
10.3 Acetazolamide Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Acetazolamide Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Acetazolamide Drug in Global Market
Table 2. Top Acetazolamide Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Acetazolamide Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Acetazolamide Drug Revenue Share by Companies, 2018-2023
Table 5. Global Acetazolamide Drug Sales by Companies, (K Units), 2018-2023
Table 6. Global Acetazolamide Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Acetazolamide Drug Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Acetazolamide Drug Product Type
Table 9. List of Global Tier 1 Acetazolamide Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acetazolamide Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Acetazolamide Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Acetazolamide Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Acetazolamide Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Acetazolamide Drug Sales (K Units), 2018-2023
Table 15. By Type - Global Acetazolamide Drug Sales (K Units), 2024-2029
Table 16. By Application – Global Acetazolamide Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Acetazolamide Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Acetazolamide Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Acetazolamide Drug Sales (K Units), 2018-2023
Table 20. By Application - Global Acetazolamide Drug Sales (K Units), 2024-2029
Table 21. By Region – Global Acetazolamide Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Acetazolamide Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Acetazolamide Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Acetazolamide Drug Sales (K Units), 2018-2023
Table 25. By Region - Global Acetazolamide Drug Sales (K Units), 2024-2029
Table 26. By Country - North America Acetazolamide Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Acetazolamide Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Acetazolamide Drug Sales, (K Units), 2018-2023
Table 29. By Country - North America Acetazolamide Drug Sales, (K Units), 2024-2029
Table 30. By Country - Europe Acetazolamide Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Acetazolamide Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Acetazolamide Drug Sales, (K Units), 2018-2023
Table 33. By Country - Europe Acetazolamide Drug Sales, (K Units), 2024-2029
Table 34. By Region - Asia Acetazolamide Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Acetazolamide Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Acetazolamide Drug Sales, (K Units), 2018-2023
Table 37. By Region - Asia Acetazolamide Drug Sales, (K Units), 2024-2029
Table 38. By Country - South America Acetazolamide Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Acetazolamide Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Acetazolamide Drug Sales, (K Units), 2018-2023
Table 41. By Country - South America Acetazolamide Drug Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Acetazolamide Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Acetazolamide Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Acetazolamide Drug Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Acetazolamide Drug Sales, (K Units), 2024-2029
Table 46. Teva Company Summary
Table 47. Teva Acetazolamide Drug Product Offerings
Table 48. Teva Acetazolamide Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Teva Key News & Latest Developments
Table 50. TARO Company Summary
Table 51. TARO Acetazolamide Drug Product Offerings
Table 52. TARO Acetazolamide Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. TARO Key News & Latest Developments
Table 54. Zydus Pharmaceuticals Company Summary
Table 55. Zydus Pharmaceuticals Acetazolamide Drug Product Offerings
Table 56. Zydus Pharmaceuticals Acetazolamide Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Zydus Pharmaceuticals Key News & Latest Developments
Table 58. Lannett Company Company Summary
Table 59. Lannett Company Acetazolamide Drug Product Offerings
Table 60. Lannett Company Acetazolamide Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Lannett Company Key News & Latest Developments
Table 62. Sun Pharmaceutical Company Summary
Table 63. Sun Pharmaceutical Acetazolamide Drug Product Offerings
Table 64. Sun Pharmaceutical Acetazolamide Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Sun Pharmaceutical Key News & Latest Developments
Table 66. Heritage Pharmaceuticals Company Summary
Table 67. Heritage Pharmaceuticals Acetazolamide Drug Product Offerings
Table 68. Heritage Pharmaceuticals Acetazolamide Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Heritage Pharmaceuticals Key News & Latest Developments
Table 70. Nostrum Laboratories Company Summary
Table 71. Nostrum Laboratories Acetazolamide Drug Product Offerings
Table 72. Nostrum Laboratories Acetazolamide Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Nostrum Laboratories Key News & Latest Developments
Table 74. Accord Healthcare Company Summary
Table 75. Accord Healthcare Acetazolamide Drug Product Offerings
Table 76. Accord Healthcare Acetazolamide Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Accord Healthcare Key News & Latest Developments
Table 78. Strides Pharma Company Summary
Table 79. Strides Pharma Acetazolamide Drug Product Offerings
Table 80. Strides Pharma Acetazolamide Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Strides Pharma Key News & Latest Developments
Table 82. West-Ward Pharmaceuticals Company Summary
Table 83. West-Ward Pharmaceuticals Acetazolamide Drug Product Offerings
Table 84. West-Ward Pharmaceuticals Acetazolamide Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. West-Ward Pharmaceuticals Key News & Latest Developments
Table 86. X-Gen Pharmaceuticals Company Summary
Table 87. X-Gen Pharmaceuticals Acetazolamide Drug Product Offerings
Table 88. X-Gen Pharmaceuticals Acetazolamide Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. X-Gen Pharmaceuticals Key News & Latest Developments
Table 90. Mylan Company Summary
Table 91. Mylan Acetazolamide Drug Product Offerings
Table 92. Mylan Acetazolamide Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Mylan Key News & Latest Developments
Table 94. Emcure Company Summary
Table 95. Emcure Acetazolamide Drug Product Offerings
Table 96. Emcure Acetazolamide Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Emcure Key News & Latest Developments
Table 98. Acetazolamide Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 99. Global Acetazolamide Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Acetazolamide Drug Production by Region, 2018-2023 (K Units)
Table 101. Global Acetazolamide Drug Production by Region, 2024-2029 (K Units)
Table 102. Acetazolamide Drug Market Opportunities & Trends in Global Market
Table 103. Acetazolamide Drug Market Drivers in Global Market
Table 104. Acetazolamide Drug Market Restraints in Global Market
Table 105. Acetazolamide Drug Raw Materials
Table 106. Acetazolamide Drug Raw Materials Suppliers in Global Market
Table 107. Typical Acetazolamide Drug Downstream
Table 108. Acetazolamide Drug Downstream Clients in Global Market
Table 109. Acetazolamide Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Acetazolamide Drug Segment by Type in 2022
Figure 2. Acetazolamide Drug Segment by Application in 2022
Figure 3. Global Acetazolamide Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Acetazolamide Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Acetazolamide Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Acetazolamide Drug Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Acetazolamide Drug Revenue in 2022
Figure 9. By Type - Global Acetazolamide Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Acetazolamide Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Acetazolamide Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Acetazolamide Drug Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Acetazolamide Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Acetazolamide Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Acetazolamide Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Acetazolamide Drug Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Acetazolamide Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Acetazolamide Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Acetazolamide Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Acetazolamide Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Acetazolamide Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Acetazolamide Drug Sales Market Share, 2018-2029
Figure 23. US Acetazolamide Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Acetazolamide Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Acetazolamide Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Acetazolamide Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Acetazolamide Drug Sales Market Share, 2018-2029
Figure 28. Germany Acetazolamide Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Acetazolamide Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Acetazolamide Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Acetazolamide Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Acetazolamide Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Acetazolamide Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Acetazolamide Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Acetazolamide Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Acetazolamide Drug Sales Market Share, 2018-2029
Figure 37. China Acetazolamide Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Acetazolamide Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Acetazolamide Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Acetazolamide Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Acetazolamide Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Acetazolamide Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Acetazolamide Drug Sales Market Share, 2018-2029
Figure 44. Brazil Acetazolamide Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Acetazolamide Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Acetazolamide Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Acetazolamide Drug Sales Market Share, 2018-2029
Figure 48. Turkey Acetazolamide Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Acetazolamide Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Acetazolamide Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Acetazolamide Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Acetazolamide Drug Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Acetazolamide Drug by Region, 2022 VS 2029
Figure 54. Acetazolamide Drug Industry Value Chain
Figure 55. Marketing Channels

※参考情報

アセタゾラミドは、主に炭酸脱水酵素阻害剤として分類される医薬品であり、さまざまな用途があります。特に、高山病や緑内障、尿路結石の予防・治療などに用いられます。本薬は1950年代から使用されており、その効果と安全性から、今でも広く用いられています。

アセタゾラミドの基本的な作用機序は、炭酸脱水酵素を阻害することによって、二酸化炭素と水から炭酸水素イオンを生成する反応を抑制する点にあります。この反応が抑制されることで、体内の酸塩基平衡に影響を与え、様々な生理的な効果がもたらされます。具体的には、尿中における重炭酸イオンの排出を促進し、体内の酸性度を高めることで、特定の病状に効果を発揮します。

この薬剤の特徴には、俊敏な作用と比較的短い半減期があります。一般的に、服用後数時間で効果が現れ、24時間以内にほぼ排泄されます。そのため、連続的に使用する場合は、適切な投与間隔を保つ必要があります。また、耐性の形成が少ないため、長期間使用しても効果を維持しやすいと言われています。

アセタゾラミドには、いくつかの製剤形態があります。一般的には、経口剤としてタブレットやカプセルなどが用いられますが、注射剤も存在します。医師の判断に基づき、患者の状態や病状に応じて適切な製剤を選択することが重要です。

用途としては、高山病の予防が挙げられます。高度な場所に移動する際、高山病を予防するために使用されることが多いです。高山病は、低酸素環境に適応できないことから生じる症状であり、アセタゾラミドは体の酸素利用効率を改善することで症状を軽減します。

緑内障の治療にも用いられます。緑内障は、眼圧が高くなり、視神経にダメージを与える病気です。アセタゾラミドは、眼内流体の生成を抑える作用があるため、眼圧を下げる効果があります。特に、他の降圧剤が効果を示さない場合や、急性緑内障の発作時にも使用されることがあります。

さらに、腎臓の働きに関連する病状、例えば尿路結石の予防や治療にも効果があるとされています。尿中のpHが低下することで、石の形成を阻止するメカニズムがあります。このため、石の成分がカルシウムを多く含む場合に特に有効とされています。

また、アセタゾラミドは特定の神経疾患や心疾患の補助療法としても使われることがあり、例えばてんかんや心不全においてもその効果が研究されています。脳内の酸塩基平衡を調整することで、神経活動を安定化させる働きがあります。

このように多様な用途があるアセタゾラミドですが、副作用も存在します。一般的には、頭痛や吐き気、めまい、手足のしびれなどが報告されています。また、長期間の使用にあたっては電解質異常が起こることもあり、特にカリウムの低下が懸念されるため、定期的な血液検査が推奨されます。

併用禁忌や注意すべき薬剤との相互作用も存在しますので、使用する際は医師の指導を仰ぐことが重要です。他の利尿剤や降圧剤との併用には注意が必要であり、特に腎機能に問題がある患者には慎重な投与が求められます。

現在、アセタゾラミドは様々な研究が行われており、新たな適応症の発見や、より効果的な使用法の探求が続けられています。特に新しい神経保護作用についての研究や、がん治療への応用可能性などが検討されています。

近年の研究では、アセタゾラミドの作用を利用して、慢性障害や老化現象への対策としての応用も模索されています。これにより、今後の医療においてアセタゾラミドの位置づけがより重要になる可能性があります。

総じて、アセタゾラミドは広範な適応症を有する薬剤であり、その効果と安全性から多くの患者に使用されています。今後もさらなる研究が期待される分野であり、医薬品としての可能性は広がっていくことでしょう。患者の生活の質を向上させるために、この薬剤の理解を深めていくことが、医療従事者に求められています。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ アセタゾラミド薬の世界市場見通し2023年-2029年(Acetazolamide Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

アセタゾラミド薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp